Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|November 1, 1996
Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcomeG P Rizzardi, W Barcellini, G Tambussi, et al.
Clinical Immunology and Immunopathology|August 1, 1995
Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, E-selectin) and of cytokine TNF-alpha increase during interleukin-2 therapyC Fortis, L Galli, G Consogno, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1987
Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activationA Moretta, A Poggi, D Olive, et al.
The Journal of Experimental Medicine|March 1, 1990
A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic functionA Moretta, G Tambussi, C Bottino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1995
Epidemic HIV-related Kaposi's sarcoma: a retrospective analysis and validation of TIS staging. GICAT. Gruppo Italiano Collaborativo AIDS e TumoriG Tambussi, L Repetto, V Torri, et al.
Science & Sports|February 14, 2022
Cardiac involvement in athletes infected by SARS COV-2 diseaseJ S Tasca, G Bianchi, A Girardello, et al.
Clinical Immunology (Orlando, Fla.)|April 5, 2001
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individualsC Bovolenta, L Camorali, M Mauri, et al.
European Journal of Immunology|January 1, 1989
Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytesS Ferrini, I Prigione, C Bottino, et al.
The Journal of Experimental Medicine|July 1, 1988
Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transductionG Pantaleo, M R Zocchi, S Ferrini, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1989
Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cellsA Moretta, E Ciccone, G Tambussi, et al.
Pageof 11